And in MDS, it's 1.5 years.

Source: https://seekingalpha.com/article/4651684-syros-pharmaceuticals-inc-syrs-q3-2023-earnings-call-transcript?source=feed_all_articles

Humphreys may have not known what to do, but someone in the community did—they contacted MDS.

Source: https://mbherald.com/god-turns-things-out-for-ourbetter/?utm_source=rss&utm_medium=rss&utm_campaign=god-turns-things-out-for-ourbetter

So, there are four factors MDS uses before deciding which of the many communities in need of help to make the long-term commitment to.

Source: https://wbhm.org/2023/while-rebuilding-homes-amish-volunteers-bond-with-south-louisiana-over-faith-and-food/

The Phase 1 trial is a multi-arm dose escalation study evaluating TSC-100, TSC-101, or HCT alone in patients with AML, ALL or MDS undergoing haploidentical allogeneic HCT with reduced intensity conditioning.

Source: https://forextv.com/top-news/tscan-therapeutics-presents-initial-phase-1-clinical-results-on-tsc-100-and-tsc-101-at-the-65th-american-society-of-hematology-annual-meeting-and-exposition/